Acurx Pharmaceuticals Lowers Stockholder Meeting Quorum to 33.3%

Acurx Pharmaceuticals, Inc. announced that its Board of Directors has approved an amendment to the Company's Bylaws. Effective October 29, 2026, the amendment reduces the quorum requirement for all stockholder meetings to one-third (33.3%) of the voting power of the stock outstanding and entitled to vote, unless otherwise required by law or the Company's Certificate of Incorporation. Previously, a majority of the shares entitled to vote constituted a quorum.